Management of cardiogenic shock complicating myocardial infarction

A Mebazaa, A Combes, S van Diepen, A Hollinger, JN Katz, G Landoni, LA Hajjar, J Lassus, G Lebreton, G Montalescot, JJ Park, S Price, A Sionis, D Yannopolos, VP Harjola, B Levy, H Thiele

Research output: Contribution to journalArticlepeer-review

Abstract

Up to 10% of acute coronary syndromes are complicated by cardiogenic shock (CS) with contemporary mortality rates of 40–50%. The extent of ischemic myocardium has a profound impact on the initial, in-hospital, and post-discharge management and prognosis in this patient population. Individualized patient risk assessment plays an important role in determining appropriate revascularization, drug treatment with inotropes and vasopressors, mechanical circulatory support, intensive care support of other organ systems, hospital level of care triage, and allocation of clinical resources. This review will outline the underlying causes and diagnostic criteria, pathophysiology, and treatment of CS complicating acute coronary syndromes with a focus on (a) potential therapeutic issues from the perspective an interventional cardiologist, an emergency physician, and an intensive care physician, (b) the type of revascularization, and (c) new therapeutic advancements in pharmacologic and mechanical percutaneous circulatory support. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature and ESICM.
Original languageEnglish
Pages (from-to)760-773
Number of pages14
JournalIntensive Care Medicine
Volume44
Issue number6
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'Management of cardiogenic shock complicating myocardial infarction'. Together they form a unique fingerprint.

Cite this